H.MohanB
Youre not alone, dosage is the number-one question people ask about this peptide
On the other hand, the adverse events of GLP-1 drugs have been extensively characterized from large randomized trials with placebo controls and, in the United States, from reports derived from 12% of Americans who are currently taking these drugs
There is no known pharmacological interaction from same-day administration
This goes with its ample range of beneficial effects, obtained within the same dose range [1,2,3,4,5,6,7,8,9,10,11,15,27,28,29,30,33,109,124,125], as the most valuable proof of the neurotransmitter requires that the application of the chemical directly to the target cells should produce the same response observed when the chemical is naturally released from the neurons [12,13,14]
When n=3, 18 samples can be assayed (when there is no coloration in the sample)